EHC: Hypercoagulability After Breast Cancer Surgery
Sponsor
Institut Bergonié (Other)
Overall Status
Completed
CT.gov ID
NCT00210197
Collaborator
(none)
48
1
12
4
Study Details
Study Description
Brief Summary
The risk of deep venous thrombosis after radical breast surgery is known. The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before, during and after surgery. Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively. Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin, D-dimer and the endogen thrombin potential.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
48 participants
Time Perspective:
Prospective
Official Title:
Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery
Study Start Date
:
Jan 1, 2005
Actual Study Completion Date
:
Jan 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
-
Breast cancer
-
mastectomy
Exclusion criteria:
-
thrombophilia
-
anticoagulant treatment
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest | Bordeaux | France | 33076 |
Sponsors and Collaborators
- Institut Bergonié
Investigators
- Principal Investigator: Youssef KABBANI, MD, Institut Bergonié
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00210197
Other Study ID Numbers:
- IB2005-06
- EHC
First Posted:
Sep 21, 2005
Last Update Posted:
Jul 26, 2013
Last Verified:
Oct 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: